Ask the Expert: XRT Needed in Addition to FOLFOX in Resected Cecal Cancer?

2011 Nov 28, Axel Grothey, MD

Abstract

"Ask the Expert” features answers by our experts to your clinical questions. Question: The patient is a 56-year-old woman with poorly differentiated adenocarcinoma of the cecum with two positive lymph nodes. There was peritoneal involvement through adherence to the anterior abdominal wall over the span of 3cm. but this area underwent R0 resection. The patient also has a BRCA1 mutation with a past medical history significant for breast cancer. She has had bilateral mastectomies and prophylactic bilateral...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Seminal Articles

The definitive list of must-read articles for practicing oncologists

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration